BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28212898)

  • 1. Low serum iron is associated with high serum intact FGF23 in elderly men: The Swedish MrOS study.
    Lewerin C; Ljunggren Ö; Nilsson-Ehle H; Karlsson MK; Herlitz H; Lorentzon M; Ohlsson C; Mellström D
    Bone; 2017 May; 98():1-8. PubMed ID: 28212898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma fibroblast growth factor 23 concentration and iron status. Does the relationship exist in the elderly population?
    Bożentowicz-Wikarek M; Kocełak P; Owczarek A; Olszanecka-Glinianowicz M; Mossakowska M; Skalska A; Więcek A; Chudek J
    Clin Biochem; 2015 Apr; 48(6):431-6. PubMed ID: 25583093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men.
    Marsell R; Mirza MA; Mallmin H; Karlsson M; Mellström D; Orwoll E; Ohlsson C; Jonsson KB; Ljunggren O; Larsson TE
    Osteoporos Int; 2009 Jul; 20(7):1167-73. PubMed ID: 18974917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Plasma Erythropoietin Predicts Incident Fractures in Elderly Men with Normal Renal Function: The MrOS Sweden Cohort.
    Kristjansdottir HL; Lewerin C; Lerner UH; Herlitz H; Johansson P; Johansson H; Karlsson M; Lorentzon M; Ohlsson C; Ljunggren Ö; Mellström D
    J Bone Miner Res; 2020 Feb; 35(2):298-305. PubMed ID: 31626711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
    Marsell R; Grundberg E; Krajisnik T; Mallmin H; Karlsson M; Mellström D; Orwoll E; Ohlsson C; Jonsson KB; Ljunggren O; Larsson TE
    Eur J Endocrinol; 2008 Jan; 158(1):125-9. PubMed ID: 18166826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphate control in reducing FGF23 levels in hemodialysis patients.
    Rodelo-Haad C; Rodríguez-Ortiz ME; Martin-Malo A; Pendon-Ruiz de Mier MV; Agüera ML; Muñoz-Castañeda JR; Soriano S; Caravaca F; Alvarez-Lara MA; Felsenfeld A; Aljama P; Rodriguez M
    PLoS One; 2018; 13(8):e0201537. PubMed ID: 30086150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.
    van Breda F; Emans ME; van der Putten K; Braam B; van Ittersum FJ; Kraaijenhagen RJ; de Borst MH; Vervloet M; Gaillard CA
    PLoS One; 2015; 10(6):e0128994. PubMed ID: 26079688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast Growth Factor 23 (FGF23) and Klotho Protein in Beta-Thalassemia.
    Stefanopoulos D; Nasiri-Ansari N; Dontas I; Vryonidou A; Galanos A; Psaridi L; Fatouros IG; Mastorakos G; Papavassiliou AG; Kassi E; Tournis S
    Horm Metab Res; 2020 Mar; 52(3):194-201. PubMed ID: 32215890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal fibroblast growth factor 23 levels of maintenance haemodialysis patients.
    Yamashita K; Mizuiri S; Nishizawa Y; Kenichiro S; Doi S; Masaki T
    Nephrology (Carlton); 2017 Dec; 22(12):947-953. PubMed ID: 27558654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysequilibrium of the PTH-FGF23-vitamin D axis in relapsing remitting multiple sclerosis; a longitudinal study.
    Stein MS; Ward GJ; Butzkueven H; Kilpatrick TJ; Harrison LC
    Mol Med; 2018 May; 24(1):27. PubMed ID: 30134801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.
    Wolf M; Koch TA; Bregman DB
    J Bone Miner Res; 2013 Aug; 28(8):1793-803. PubMed ID: 23505057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.
    Emrich IE; Brandenburg V; Sellier AB; Schauerte J; Wiedenroth J; Untersteller K; Lennartz CS; Seiler-Mussler S; Wagenpfeil S; Fliser D; Heine GH
    Am J Nephrol; 2019; 49(3):203-211. PubMed ID: 30808827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study.
    Eisenga MF; De Jong MA; Van der Meer P; Leaf DE; Huls G; Nolte IM; Gaillard CAJM; Bakker SJL; De Borst MH
    PLoS Med; 2019 Jun; 16(6):e1002818. PubMed ID: 31170159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum estradiol associates with blood hemoglobin in elderly men: the MrOS Sweden study.
    Lewerin C; Nilsson-Ehle H; Jacobsson S; Johansson H; Sundh V; Karlsson MK; Lorentzon M; Barrett-Connor E; Vandenput L; Ohlsson C; Mellström D
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2549-56. PubMed ID: 24731011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum fibroblast growth factor 23, serum iron and bone mineral density in premenopausal women.
    Imel EA; Liu Z; McQueen AK; Acton D; Acton A; Padgett LR; Peacock M; Econs MJ
    Bone; 2016 May; 86():98-105. PubMed ID: 26965530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly.
    Chudek J; Kocełak P; Owczarek A; Bożentowicz-Wikarek M; Mossakowska M; Olszanecka-Glinianowicz M; Wiecek A
    Nephrol Dial Transplant; 2014 Sep; 29(9):1757-63. PubMed ID: 24729016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-Terminal to Intact Fibroblast Growth Factor 23 Ratio in Relation to Estimated Glomerular Filtration Rate in Elderly Population.
    Bożentowicz-Wikarek M; Owczarek A; Kocełak P; Olszanecka-Glinianowicz M; Więcek A; Chudek J
    Kidney Blood Press Res; 2016; 41(5):519-526. PubMed ID: 27529627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum phosphate and phosphate-regulatory hormones in COPD patients.
    Stroda A; Brandenburg V; Daher A; Cornelissen C; Goettsch C; Keszei A; Dreher M
    Respir Res; 2018 Sep; 19(1):183. PubMed ID: 30236113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients.
    Dounousi E; Torino C; Pizzini P; Cutrupi S; Panuccio V; D'Arrigo G; Abd ElHafeez S; Tripepi G; Mallamaci F; Zoccali C
    Eur J Clin Invest; 2016 Mar; 46(3):234-41. PubMed ID: 26728476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.
    Mirza MA; Alsiö J; Hammarstedt A; Erben RG; Michaëlsson K; Tivesten A; Marsell R; Orwoll E; Karlsson MK; Ljunggren O; Mellström D; Lind L; Ohlsson C; Larsson TE
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):219-27. PubMed ID: 20966399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.